The FDA cleared EchoNext, the first artificial intelligence tool to detect structural heart disease before symptoms present.
In patients with T2D and CKD, finerenone lowers the risk for adverse cardiovascular and kidney events compared with placebo, ...
Elizabeth Cooney became STAT’s cardiovascular reporter in April with one fundamental question in mind: Why do we have so much cardiovascular and metabolic disease, and how can we do better? Liz covers ...
1don MSN
Doctor Shares If Menstrual Cycle Phase Should Become A Routine Part Of Cardiovascular Assessments
As heart disease is increasingly recognised in younger women, incorporating menstrual history into cardiovascular assessment ...
The 2026 ACC/AHA guidelines outline staging, risk assessment, and interdisciplinary care for CKM syndrome management.
Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Where do we stand on ...
Background Despite advances in acute coronary syndrome (ACS) management, contemporary data assessing long-term prognosis ...
BACKGROUND: Cardiovascular diseases (CVD) are leading causes of morbidity and mortality among patients with ...
Recent research has explored how the medium-chain triglyceride may affect fat processing and cardiovascular function.
Cardiovascular disease remains the leading cause of death globally. To address this burden on health-care systems around the world, an in-depth understanding is needed about the incidence and ...
Selective cyclooxygenase-2 (COX-2) inhibitors have come under scrutiny because of reports suggesting an increased cardiovascular risk associated with their use. Experimental research suggesting that ...
The National Health Fund (NHF) has increased subsidies on 18 cardiovascular drug items, with increases ranging from $40 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results